Podcasts

Voices of Biotech: Bayer on why female role models matter

“Women and people of diverse backgrounds remain underrepresented in the upper echelons of the biopharma C-suite,” says Ilona Gutcher, director of BD&L Oncology at Bayer. Aligning with International Women’s Day (Wednesday 8th March) the BioProcess Insider Expression Platform has released its second episode of Voices of Biotech. “I wouldn’t be here without the I&D Xcelerate program,” says Gutcher, another graduate of the Bayer program launched by Marianne De backer two years ago to promote diversity through a 6–9 month placement…

Voices of Biotech: Bayer VP on driving diversity in life sciences

Deepa Talpade discusses how women can reach their full potential in life sciences through schemes like Bayer’s I&D Xcelerate program in the first episode of our Voices of Biotech podcast. Concurrent with International Day of Women and Girls in Science (Friday 10 February), the BioProcess Insider Expression Platform has launched Voices of Biotech – a podcast that celebrates women and minorities in science and what more can be done to amplify their voices. Despite the progress over the last decade,…

Podcast: From platform to patient, CGTs must be more accessible

We sit down with Ori Biotech’s CEO Jason Foster to discuss the company’s paperless platform journey to commercialization and to delve deep into the challenges associated with accessing advanced therapies. This episode of the BioProcess Insider Expression Platform (BIEP) podcast brings you an in-depth conversation with Jason Foster, CEO of Ori Biotech. The company experienced a year of transition in 2022 with the closing of its $100 million Series B funding round and the expansion of its paperless cell and…

Ireland’s in the (up/down) stream: NIBRT talks bioproduction

The latest edition of the BioProcess Insider Expression Platform has NIBRT’s Killian O’Driscoll speaking on Ireland’s robust biomanufacturing environment, training programs, and vendor-led technologies. Ireland has long established itself as a drug manufacturing hub and is home to commercial production sites run by Big Pharma firms including Pfizer, J&J, Eli Lilly, and AstraZeneca, as well as numerous third-party manufacturing organizations and bioprocess vendor firms. The country has evolved to mirror industry’s shift from small molecule to large molecule, and now…

Podcast: Selecting a CDMO? Know your molecule, know your timeline

With expertise in development and CMC in short supply globally, CDMO choice is absolutely critical for sponsors relying on them to accelerate development pathway, says Pharmatech Associates. Ahead of November’s CPhI Worldwide event in Frankfurt, Germany, BioProcess Insider hosted a LinkedIn Live discussion with Bikash Chatterjee and Stephanie Gaulding, the respective CEO and MD at drug development consultancy firm Pharmatech Associates about current outsourcing strategies and how to go about selecting a CDMO partner. Listen to the full discussion, as…

Podcast: Turning out talent and the trials of training in the bioprocess space

Training, virtual reality, and uptake in courses are all critical factors that need to be addressed to meet the demand for talent in the advanced therapy space, according to industry academics. This episode of the BioProcess Insider Expression Platform (BIEP) podcast brings you an in-depth conversation with Stuart Curbishley, head of business and project development, advanced therapies at University of Birmingham and Ivan Wall, CEO, Four-Plus and director of the National Training Center for advanced therapies manufacturing. We delve deep into…

Podcast: Lumen using spirulina to make ‘edible’ antibody drugs

We sit down with Lumen Biosciences CEO Brian Finrow to discuss how his company hopes to use its spirulina-based platform to develop drugs targeting gastrointestinal disorders. Lumen Biosciences is a biotech looking to unlock the full potential of biologic drugs, whose promise has been held back by the lack of scalable technology. The firm is developing ‘oral antibodies’ using its platform based on spirulina– the protein-rich cyanobacteria touted by many health enthusiasts as a ‘superfood’ – to create tiny factories…

Podcast: Cytiva cites COVID as driver for biopharma resilience

Emmanuel Ligner, CEO of self-described bioprocess “critical actor” Cytiva talks us through the changing biomanufacturing landscape and unveils his firm’s sustainability report in the latest BioProcess Insider Expression Platform podcast. In 2021, Cytiva launched a survey measuring industry’s confidence in the biopharma space. Focusing across five pillars – supply chain resilience, talent pool, the R&D ecosystem, manufacturing agility, and government policy and regulation – the Biopharma Resilience Index averaged an overall score of 6.6 out of 10 in 2021. Feedback from 2022’s…

Podcast: Fujifilm Diosynth CEO on pandemics, CAPEX, and CGT ambitions

Martin Meeson discusses Fujifilm Diosynth Biotechnologies’s role in pandemics past and future, and why the CDMO just won’t stop investing in capacity. The BioProcess Insider Expression Platform (BIEP) is back, bringing you some of the conversations you may have missed at BIO 2022 in San Diego, California. We sat down with Martin Meeson, CEO of Fujifilm Diosynth Biotechnologies, to discuss industry’s learnings from the pandemic. “[COVID-19] was a pandemic but I just worry we forget and we won’t use the…

Podcast: Opening the gates for women in biotech

There is no lack of talented women in the biotech space but the gates blocking their progression must be open for them to fully realize their potential, says consultant Nadine Ritter. Companies’ Diversity, Equality, and Inclusion (DEI) policies are too often just an exercise in box-checking, said Nadine Ritter, president and analytical advisor at Global Biotech Experts and long-time member of BioProcess International’s editorial board. “If it’s just virtual signaling on a website then I don’t care… show me the…